Clinical Trial Update: A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for ROC-101 in patients with pulmonary arterial hypertension and pulmonary hypertension due to interstitial lung disease, curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Pulmonary Hypertension Due to Interstitial Lung Disease

Drugs mentioned

• ROC-101

Snippet

Sponsor: AllRock Bio, Inc. | Conditions: Pulmonary Arterial Hypertension (PAH), Pulmonary Hypertension, Interstitial Lung Disease | Phase 2 | Status: RECRUITING